PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-May-2020 TPX-100:  OrthoTrophix Presents More Evidence for Disease Modification in Knee Osteoarthritis in a New Abstract Published in Osteoarthritis & Cartilage Journal OrthoTrophix, Inc.
12-May-2020 Zymo Research Obtains Emergency Use Authorization from FDA for Their Quick SARS-CoV-2 rRT-PCR Kit Zymo Research Corp.
12-May-2020 Pharmaceutical Continuous Manufacturing Market Analysis - New Opportunities Explored, High CAGR & ROI Anticipated Till 2024: Radiant Insights, Inc. Radiant Insights, Inc.
12-May-2020 Pharmaceutical Continuous Manufacturing Market Analysis - New Opportunities Explored, High CAGR & ROI Anticipated Till 2024: Radiant Insights, Inc. Radiant Insights, Inc.
12-May-2020 Zymo Research Obtains Emergency Use Authorization from FDA for Their Quick SARS-CoV-2 rRT-PCR Kit Zymo Research Corp.
12-May-2020 Zymo Research Obtains Emergency Use Authorization from FDA for Their Quick SARS-CoV-2 rRT-PCR Kit Zymo Research Corp.
12-May-2020 Zymo Research Obtains Emergency Use Authorization from FDA for Their Quick SARS-CoV-2 rRT-PCR Kit Zymo Research Corp.
12-May-2020 Pharmaceutical Continuous Manufacturing Market Analysis - New Opportunities Explored, High CAGR & ROI Anticipated Till 2024: Radiant Insights, Inc. Radiant Insights, Inc.
12-May-2020 Q1 Performance Stable despite Oil Price Slump and Corona Expenses. Strong Growth in Radiopharmaceutical Products Eckert & Ziegler Strahlen- und Medizintechnik AG
12-May-2020 AEVIS VICTORIA SA: consolidated revenues for the first quarter of 2020 reach CHF 194.8 million, up 9.9% due to acquisitions AEVIS VICTORIA SA
12-May-2020 Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Postpones Annual General Meeting Vivoryon Therapeutics AG
12-May-2020 Sutro Biopharma Announces Pricing of $85.3 Million Public Offering Sutro Biopharma
11-May-2020 Coronavirus (COVID-19) Update: FDA updates on surveillance inspections during COVID-19 U.S. Food and Drug Administration
11-May-2020 Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference Kodiak Sciences Inc.
11-May-2020 Vibativ® Sustained Potency Confirmed In Two Surveillance Studies Cumberland Pharmaceuticals Inc.
11-May-2020 INOVIO Reports First Quarter 2020 Financial Results; Provides Business Update INOVIO Pharmaceuticals, Inc.
11-May-2020 Marker Therapeutics Reports First Quarter 2020 Operating and Financial Results Marker Therapeutics, Inc.
11-May-2020 DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs DURECT Corporation
11-May-2020 Titan Pharmaceuticals To Report First Quarter 2020 Financial Results On May 15, 2020 Titan Pharmaceuticals, Inc.
11-May-2020 Neurocrine Biosciences Exercises Option to License Idorsia's Novel Treatment for Rare Pediatric Epilepsy Neurocrine Biosciences, Inc.